Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Phys Rev Lett ; 61(1): 23-26, 1988 Jul 04.
Article in English | MEDLINE | ID: mdl-10038684
2.
Phys Rev C Nucl Phys ; 37(2): 786-796, 1988 Feb.
Article in English | MEDLINE | ID: mdl-9954499
4.
Phys Rev Lett ; 59(6): 736-739, 1987 Aug 10.
Article in English | MEDLINE | ID: mdl-10035857
6.
NIDA Res Monogr ; (9): 88-92, 1976 Sep.
Article in English | MEDLINE | ID: mdl-794726

ABSTRACT

Our studies have shown no evidence of toxicity and few side effects from naltrexone. It is a valuable adjunct in treating addicts who wish to be opiate free. Patients who drop out and return to treatment tend to remain longer with each successive readmission. Naltrexone has special potential for persons, such as an opiate-abusing physician for whom methadone maintenance is clearly inappropriate. A double-blind study has suggested that it may have value as a transitional treatment for detoxified methadone maintenance patients. Differences between naltrexone and cyclazocine suggest that a treatment combining these drugs should be explored.


Subject(s)
Naloxone/analogs & derivatives , Naltrexone/therapeutic use , Substance-Related Disorders/rehabilitation , Clinical Trials as Topic , Cyclazocine/therapeutic use , Drug Administration Schedule , Humans , Methadone/administration & dosage , Methadone/therapeutic use , Naltrexone/adverse effects , Patient Compliance , Physicians , Placebos , Research Personnel
SELECTION OF CITATIONS
SEARCH DETAIL